TY - JOUR
T1 - Erratum
T2 - Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint (npj Breast Cancer, (2018), 4, 1, (26), 10.1038/s41523-018-0074-6)
AU - I-SPY2 Investigators
AU - Boughey, Judy C.
AU - Alvarado, Michael D.
AU - Lancaster, Rachael B.
AU - Symmans, W. Fraser
AU - Mukhtar, Rita
AU - Wong, Jasmine M.
AU - Ewing, Cheryl A.
AU - Potter, David A.
AU - Tuttle, Todd M.
AU - Hieken, Tina J.
AU - Carter, Jodi M.
AU - Jakub, James W.
AU - Kaplan, Henry G.
AU - Buchanan, Claire L.
AU - Jaskowiak, Nora T.
AU - Sattar, Husain A.
AU - Mueller, Jeffrey
AU - Nanda, Rita
AU - Isaacs, Claudine J.
AU - Pohlmann, Paula R.
AU - Lynce, Filipa
AU - Tousimis, Eleni A.
AU - Zeck, Jay C.
AU - Lee, M. Catherine
AU - Lang, Julie E.
AU - Mhawech-Fauceglia, Paulette
AU - Rao, Roshni
AU - Taback, Bret
AU - Goodellas, Constantine
AU - Chen, Margaret
AU - Kalinsky, Kevin M.
AU - Hibshoosh, Hanina
AU - Killelea, Brigid
AU - Sanft, Tara
AU - Hirst, Gillian L.
AU - Asare, Smita
AU - Matthews, Jeffrey B.
AU - Perlmutter, Jane
AU - Esserman, Laura J.
AU - Chien, A. Jo
AU - Forero-Torres, Andres
AU - Yee, Douglas
AU - Ellis, Erin D.
AU - Han, Heather S.
AU - Lu, Janice
AU - Wallace, Anne M.
AU - Albain, Kathy S.
AU - Elias, Anthony D.
AU - Clark, Amy S.
AU - Kemmer, Kathleen
N1 - Publisher Copyright:
© 2019, The Author(s).
PY - 2019/12/1
Y1 - 2019/12/1
N2 - In the original version of the published article, Constantine Godellas was mistakenly omitted from the Author list and Author Contributions statement. Constantine Godellas has been added as the 29th Author, and is affiliated with Loyola University Medical Center, Maywood, IL, United States. The author contributions statement has been updated as follows: “Author Contributions Statement: Judy C. Boughey conducted the review of current protocols, led the effort to establish new I-SPY standards and was the principal author of the manuscript. Laura Esserman co-led the review and standardization processes. Michael D. Alvarado, Rachael B. Lancaster, Fraser Symmans, W, Rita Mukhtar, Jasmine Wong, Cheryl Ewing, David Potter, Todd Tuttle, Tina Hieken, Jodi Carter, James Jakub, Henry Kaplan, Claire Buchanan, Nora Jaskowiak, Husain Sattar, Jeffrey Mueller, Rita Nanda, Claudine Isaacs, Paula Pohlmann, Filipa Lynce, Eleni Tousimis, Jay Zeck, M. Catherine Lee, Julie Lang, Paulette Mhawech-Fauceglia, Roshni Rao, Bret Taback, Margaret Chen, Kevin Kalinsky, Hanina Hibshoosh, Brigid Killelea, Constantine Godellas, and Tara Sanft provided medical and scientific expertise/opinion towards the development of I-SPY standards. Jane Perlmutter provided the patient advocate’s perspective in these discussions. All I-SPY2 trial investigators participated in the review of current standards, had the opportunity to participate in and comment on proposed standards and the final manuscript. Gill Hirst and Smita Asare provided expertise on, conducted and analyzed surveys of I-SPY trial sites. Jeffrey B. Matthews provided significant input and editing throughout the manuscript development process. All authors reviewed manuscript drafts and signed off on the final manuscript. This has been corrected in the HTML and PDF version of the article.
AB - In the original version of the published article, Constantine Godellas was mistakenly omitted from the Author list and Author Contributions statement. Constantine Godellas has been added as the 29th Author, and is affiliated with Loyola University Medical Center, Maywood, IL, United States. The author contributions statement has been updated as follows: “Author Contributions Statement: Judy C. Boughey conducted the review of current protocols, led the effort to establish new I-SPY standards and was the principal author of the manuscript. Laura Esserman co-led the review and standardization processes. Michael D. Alvarado, Rachael B. Lancaster, Fraser Symmans, W, Rita Mukhtar, Jasmine Wong, Cheryl Ewing, David Potter, Todd Tuttle, Tina Hieken, Jodi Carter, James Jakub, Henry Kaplan, Claire Buchanan, Nora Jaskowiak, Husain Sattar, Jeffrey Mueller, Rita Nanda, Claudine Isaacs, Paula Pohlmann, Filipa Lynce, Eleni Tousimis, Jay Zeck, M. Catherine Lee, Julie Lang, Paulette Mhawech-Fauceglia, Roshni Rao, Bret Taback, Margaret Chen, Kevin Kalinsky, Hanina Hibshoosh, Brigid Killelea, Constantine Godellas, and Tara Sanft provided medical and scientific expertise/opinion towards the development of I-SPY standards. Jane Perlmutter provided the patient advocate’s perspective in these discussions. All I-SPY2 trial investigators participated in the review of current standards, had the opportunity to participate in and comment on proposed standards and the final manuscript. Gill Hirst and Smita Asare provided expertise on, conducted and analyzed surveys of I-SPY trial sites. Jeffrey B. Matthews provided significant input and editing throughout the manuscript development process. All authors reviewed manuscript drafts and signed off on the final manuscript. This has been corrected in the HTML and PDF version of the article.
UR - http://www.scopus.com/inward/record.url?scp=85059534138&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85059534138&partnerID=8YFLogxK
U2 - 10.1038/s41523-018-0096-0
DO - 10.1038/s41523-018-0096-0
M3 - Comment/debate
C2 - 30675512
AN - SCOPUS:85059534138
SN - 2374-4677
VL - 5
JO - npj Breast Cancer
JF - npj Breast Cancer
IS - 1
M1 - 2
ER -
